Quantcast
Weekly Text Message Could Encourage Healthier Food Choices

Weekly Text Message Could Encourage Healthier Food Choices, New Study Shows

Andrea Maruniak, Johns Hopkins University Bloomberg School of Public Health Many people are unaware that the U.S. Food and Drug Administration’s mandated nutrition labels are based on a 2,000-calorie-a-day diet, but a simple weekly text...

Latest U.S. Food and Drug Administration Stories

2014-09-14 20:20:15

Analysis From SHIFT Study Shows Ivabradine Reduced Cardiovascular Death or Hospitalization for Worsening Heart Failure Independent of Baseline Blood Pressure With Similar Safety Profile Across Groups THOUSAND OAKS, Calif., Sept. 14, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced data from the Phase 3 SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study evaluating ivabradine in patients with chronic heart failure (HF) were presented at the 18(th)...

2014-09-12 12:25:14

SILVER SPRING, Md., Sept. 12, 2014 /PRNewswire-USNewswire/ -- To help kids make healthful dietary choices, the U.S. Food and Drug Administration encourages kids to Read the Label! To view the multimedia assets associated with this release, please click http://www.multivu.com/players/English/7106353-fda-national-childhood-obesity-month/ The Nutrition Facts Label is a simple tool available on food and beverage packages. It lets kids know exactly what they're eating and helps them choose and...

2014-09-10 12:28:10

The Emergence of Keytruda--the First PD-1 Inhibitor Approved in the U.S.--is a Significant Milestone in Oncology, According to Decision Resources Group BURLINGTON, Mass., Sept. 10, 2014 /PRNewswire/ -- The recent approval of Merck & Co.'s Keytruda by the U.S. Food and Drug Administration for the treatment of malignant melanoma is a significant milestone for Merck & Co. and for the oncology immunotherapy drug market. Decision Resources Group anticipates the launch of Keytruda as the...

2014-09-09 16:26:55

DUBLIN, Sept. 9, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) has voted to recommend against approval of Actavis' New Drug Application (NDA) for the fixed-dose combination of nebivolol and valsartan for the treatment of hypertension. The committee vote was six to four recommending against approval. Logo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO...

2014-09-08 23:06:47

1WorldSync announces its Global Data Synchronization Network (GDSN®) standards and Unique Device Identification (UDI) solution will be deployed by bioMérieux, a world leader in the field of in vitro diagnostics. Lawrenceville, NJ (PRWEB) September 08, 2014 1WorldSync announces its Global Data Synchronization Network (GDSN®) standards and Unique Device Identification (UDI) solution has been selected by bioMérieux, a world leader in the field of in vitro diagnostics, to...

2014-09-08 23:01:52

Harry Bell, managing partner of The Bell Law Firm and member of the Executive Committee of the Plaintiffs’ Steering Committee for Ethicon transvaginal mesh multidistrict litigation, offers insight on a West Virginia jury’s September 5 decision to award plaintiff Jo Huskey $3.27 million. CHARLESTON, W.Va. (PRWEB) September 08, 2014 Managing partner of The Bell Law Firm and member of the Executive Committee of the Plaintiffs’ Steering Committee (PSC) for the transvaginal mesh (TVM)...

2014-09-06 08:20:30

NORTHBROOK, Ill., Sept. 6, 2014 /PRNewswire/ -- Astellas today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for isavuconazole for the treatment of invasive aspergillosis and invasive mucormycosis (also known as zygomycosis), which are life-threatening fungal infections predominantly occurring in immunocompromised patients. In accordance with the FDA Prescription Drug User Fee Act (PDUFA), the FDA designated the date...

2014-09-03 23:11:45

Pew, Blue Cross Blue Shield Association, and MDEpiNet report captures recommendations of 30 diverse health care experts Washington, DC (PRWEB) September 03, 2014 Three organizations today proposed wide-ranging recommendations on the development of registries to address the country’s lack of a robust national system for assessing the safety and effectiveness of medical devices. Registries, which contain information on patients treated with specific medical devices, could fill this gap...

2014-09-03 08:34:15

SAN DIEGO, Sept. 3, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Halozyme's program investigating PEGPH20 (PEGylated recombinant human hyaluronidase) in combination with gemcitabine and nab-paclitaxel for the treatment of patients with metastatic pancreatic cancer to demonstrate an improvement in overall survival. The Fast Track designation process was developed...

2014-09-02 08:30:27

SEATTLE, Sept. 2, 2014 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) immunotherapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of motolimod (VTX-2337) when administered in combination with pegylated liposomal doxorubicin (PLD) for the treatment of women with ovarian cancer...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.